Related Experiment Videos
Moclobemide and clomipramine in endogenous depression. A randomized clinical trial
C Koczkas1, P Holm, A Karlsson
1Danderyd Hospital, Sweden.
Acta Psychiatrica Scandinavica
|June 1, 1989
Abstract:
The purpose of this study was to compare moclobemide and clomipramine in endogenous depression according to the Newcastle II classification. Sixty-two patients were allocated to either 300 mg moclobemide or 150 mg clomipramine, both given in 3 daily doses. Improvements occurred over time but differences between treatments were never statistically significant. Dizziness, tremor and anticholinergic symptoms were significantly more frequent with clomipramine.